ZCA
GILD icon

Zeke Capital Advisors’s Gilead Sciences GILD Stock Holding History

Zeke Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$563K Buy
6,561
+116
+2% +$9.19K 0.04% 223
2022
Q3 		$397K Buy
6,445
+114
+2% +$7.19K 0.03% 250
2022
Q2 		$392K Sell
6,331
-130
-2% -$8.05K 0.03% 259
2022
Q1 		$385K Buy
+6,461
New +$413K 0.02% 291
2020
Q1 		– Sell
-36,044
Closed -$2.34M – 349
2019
Q4 		$2.34M Buy
36,044
+21,872
+154% +$1.42M 0.19% 98
2019
Q3 		$898K Sell
14,172
-9,014
-39% -$589K 0.08% 214
2019
Q2 		$1.57M Buy
23,186
+775
+3% +$51K 0.15% 127
2019
Q1 		$1.46M Buy
22,411
+2,874
+15% +$191K 0.14% 131
2018
Q4 		$1.22M Buy
19,537
+1,536
+9% +$107K 0.12% 161
2018
Q3 		$1.39M Buy
18,001
+4,219
+31% +$319K 0.11% 168
2018
Q2 		$976K Sell
13,782
-20,241
-59% -$1.43M 0.09% 189
2018
Q1 		$2.56M Buy
34,023
+16,473
+94% +$1.31M 0.24% 75
2017
Q4 		$1.26M Sell
17,550
-6,422
-27% -$488K 0.13% 136
2017
Q3 		$1.94M Buy
23,972
+14,730
+159% +$1.13M 0.27% 66
2017
Q2 		$654K Sell
9,242
-6,537
-41% -$435K 0.13% 104
2017
Q1 		$1.07M Buy
15,779
+4,255
+37% +$299K 0.22% 60
2016
Q4 		$825K Buy
11,524
+8,773
+319% +$652K 0.22% 51
2016
Q3 		$204K Buy
+2,751
New +$223K 0.09% 82

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Zeke Capital Advisors's GILD Position: Q4 2022 in Review

Zeke Capital Advisors increased its Gilead Sciences (GILD) stake by 1.8% in Q4 2022, buying an estimated $9.19K and bringing the position to 6,561 shares worth $563K. The position accounts for 0.04% of the portfolio, ranked #223.

Zeke Capital Advisors first reported a position in GILD in Q3 2016 and has held it in 18 quarters since. The position peaked at $2.56M in Q1 2018. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Zeke Capital Advisors held 6,561 shares of Gilead Sciences worth $563K as of Q4 2022.
  • Zeke Capital Advisors bought 116 Gilead Sciences shares in Q4 2022, an estimated $9.19K.
  • Gilead Sciences made up 0.04% of Zeke Capital Advisors's portfolio in Q4 2022, its #223 holding.
  • Zeke Capital Advisors first reported a position in Gilead Sciences in Q3 2016 and has held it in 18 quarters since.
  • Zeke Capital Advisors's Gilead Sciences position peaked at $2.56M in Q1 2018.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.